Hypoglycaemia, a common adverse effect of treatment of diabetes mellitus with insulin and sulphonylureas, is associated with impairment of cognitive function, which can have important consequences on everyday behaviour
Adults with type 1 diabetes mellitus have ∼2 episodes of mild hypoglycaemia per week; the annual prevalence of severe hypoglycaemia is ∼30%, with several factors, such as long disease duration, increasing its incidence
Adults with insulin-treated type 2 diabetes mellitus experience a lower frequency of mild and severe hypoglycaemia episodes than those with type 1 diabetes mellitus, but frequency rises progressively with increasing duration of insulin therapy
Sympathoadrenal activation in response to hypoglycaemia has haemodynamic, haemostatic, haemorrheological and electrophysiological effects, all of which can affect cardiovascular function and potentially lead to myocardial ischaemia, cardiac arrhythmias or sudden death
Hypoglycaemia provokes neurophysiological, electrical activity and regional vascular flow changes in the brain, which can lead to coma, seizures, vascular events such as hemiplegia, and cognitive dysfunction in young children and elderly people
Prevention of hypoglycaemia depends on effective patient education, diet, exercise, frequent glucose monitoring and appropriate adjustment of therapies; new technologies, such as real-time continuous glucose monitoring and insulin pumps, might also help
Hypoglycaemia is a frequent adverse effect of treatment of diabetes mellitus with insulin and sulphonylureas. Fear of hypoglycaemia alters self-management of diabetes mellitus and prevents optimal glycaemic control. Mild (self-treated) and severe (requiring help) hypoglycaemia episodes are more common in type 1 diabetes mellitus but people with insulin-treated type 2 diabetes mellitus are also exposed to frequent hypoglycaemic events, many of which occur during sleep. Hypoglycaemia can disrupt many everyday activities such as driving, work performance and leisure pursuits. In addition to accidents and physical injury, the morbidity of hypoglycaemia involves the cardiovascular and central nervous systems. Whereas coma and seizures are well-recognized neurological sequelae of hypoglycaemia, much interest is currently focused on the potential for hypoglycaemia to cause dangerous and life-threatening cardiac complications, such as arrhythmias and myocardial ischaemia, and whether recurrent severe hypoglycaemia can cause permanent cognitive impairment or promote cognitive decline and accelerate the onset of dementia in middle-aged and elderly people with diabetes mellitus. Prevention of hypoglycaemia is an important part of diabetes mellitus management and strategies include patient education, glucose monitoring, appropriate adjustment of diet and medications in relation to everyday circumstances including physical exercise, and the application of new technologies such as real-time continuous glucose monitoring, modified insulin pumps and the artificial pancreas.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Strachan, M. W. J. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 4 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 63–95 (Wiley Blackwell, 2014).
Pramming, S., Thorsteinsson, B., Bendtson, I. & Binder, C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet. Med. 8, 217–222 (1991).
Akram, K., Pedersen-Bjergaard, U., Carstensen, B., Borch-Johnsen, K. & Thorsteinsson, B. Frequency and risk factors of severe hypoglycaemia in insulin-treated type 2 diabetes: a cross-sectional survey. Diabet. Med. 23, 750–756 (2006).
Jørgensen, H., Pedersen-Bjergaard, U., Rasmussen, A. & Borch-Johnsen, K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care 26, 1106–1109 (2003).
Schopman, J. E. & DeVries, J. H. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 9 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 184–196 (Wiley Blackwell, 2014).
McGowan, K., Thomas, W. & Moran, A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 25, 1499–1503 (2002).
Pedersen-Bjergaard, U. et al. Severe hypoglycaemia in 1,076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab. Res. Rev. 20, 479–486 (2004).
Donnelly, L. A. et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet. Med. 22, 749–755 (2005).
Ostenson, C. G. et al. Self-reported non-severe hypoglycaemic events in Europe. Diabet. Med. 31, 92–101 (2014).
Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28, 1245–1249 (2005).
Frier, B. M. Defining hypoglycaemia: what level has clinical relevance? Diabetologia 52, 31–34 (2009).
Cryer, P. E. Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia 52, 35–37 (2009).
Swinnen, S. G., Mullins, P., Miller, M., Hoekstra, J. B. & Holleman, F. Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia 52, 38–41 (2009).
Bulsara, M. K., Holman, C. D., Davis, E. A. & Jones, T. W. Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies—what method should we use? Diabet. Med. 21, 914–919 (2004).
Cox, D. J. et al. Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J. Clin. Endocrinol. Metab. 79, 1659–1662 (1994).
Kilpatrick, E. S., Rigby, A. S., Goode, K. & Atkin, S. L. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 50, 2553–2561 (2007).
Monnier, L., Wojtusciszyn, A., Colette, C. & Owens, D. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol. Ther. 13, 813–818 (2011).
[No authors listed] Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. The DCCT Research Group. Am. J. Med. 90, 450–459 (1991).
[No authors listed] The effect of intensive insulin treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977–986 (1993).
[No authors listed] Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 46, 271–286 (1997).
MacLeod, K. M., Hepburn, D. A. & Frier, B. M. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet. Med. 10, 238–245 (1993).
[No authors listed] Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37, 278–285 (1994).
ter Braak, E. W. et al. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 23, 1467–1471 (2000).
UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50, 1140–1147 (2007).
Leiter, L. A. et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can. J. Diabetes 29, 186–192 (2005).
Mühlhauser, I., Overmann, H., Bender, R., Bott, U. & Berger, M. Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes—a prospective population based study. Diabetologia 41, 1274–1282 (1998).
Kristensen, P. L. et al. Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res. Clin. Pract. 96, 17–23 (2012).
Pedersen-Bjergaard, U., Agerholm-Larsen, B., Pramming, S., Hougaard, P. & Thorsteinsson, B. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia 46, 89–96 (2003).
[No authors listed] Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care 10, 1–19 (1987).
Nielsen, L. R. et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 31, 9–14 (2008).
Hepburn, D. A., MacLeod, K. M., Pell, A. C., Scougal, I. J. & Frier, B. M. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet. Med. 10, 231–237 (1993).
Henderson, J. N., Allen, K. V., Deary, I. J. & Frier, B. M. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet .Med. 20, 1016–1021 (2003).
Allen, K. V. & Frier, B. M. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr. Pract. 9, 530–543 (2003).
Chow, E. & Heller, S. R. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 5 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 96–113 (Wiley Blackwell, 2014).
Schütt, M. et al. Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with type 1 diabetes. Diabet. Med. 29, e176–e179 (2012).
Matyka, K. A. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 10 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 197–217 (Wiley Blackwell, 2014).
Zammitt, N. N. & Frier, B. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 12 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 230–262 (Wiley Blackwell, 2014).
Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545–2559 (2008).
ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358, 2560–2572 (2008).
Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129–139 (2009).
Ryder, R. E., Owens, D. R., Hayes, T. M., Ghatei, M. A. & Bloom, S. R. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. BMJ 301, 783–787 (1990).
Graveling, A. J. & Frier, B. M. Impaired awareness of hypoglycaemia: a review. Diabetes Metab. 36 (Suppl. 3), S64–S74 (2010).
Cryer, P. E. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 369, 362–372 (2013).
White, N. H. et al. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N. Engl. J. Med. 308, 485–491 (1983).
Gold, A. E., MacLeod, K. M. & Frier, B. M. Frequency of severe hypoglycemia in patients with impaired awareness of hypoglycemia. Diabetes Care 17, 697–703 (1994).
Geddes, J., Schopman, J. E., Zammitt, N. N. & Frier, B. M. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet. Med. 25, 501–504 (2008).
Schopman, J. E., Geddes, J. & Frier, B. M. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res. Clin. Pract. 87, 64–68 (2010).
Mühlhauser, I., Toth, G., Sawicki, P. T. & Berger, M. Severe hypoglycemia in type I diabetic patients with impaired kidney function. Diabetes Care 14, 344–346 (1991).
Davis, T. M. et al. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J. Clin. Endocrinol. Metab. 95, 2240–2247 (2010).
Gold, A. E., Frier, B. M., MacLeod, K. M. & Deary, I. J. A structural equation model for predictors of severe hypoglycaemia in patients with insulin-dependent diabetes mellitus. Diabet. Med. 14, 309–315 (1997).
Punthakee, Z. et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 35, 787–793 (2012).
Faerch, L., Pedersen-Bjergaard, U. & Thorsteinsson, B. High serum ACE activity predicts severe hypoglycaemia over time in patients with type 1 diabetes. Scand. J. Clin. Lab. Med. 71, 620–624 (2011).
Bulsara, M. K. et al. The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes. Diabetologia 50, 965–971 (2007).
Zammitt, N. N. et al. Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in type 1 diabetes: does a relationship exist? Diabet. Med. 24, 1449–1454 (2007).
McAulay, V., Deary, I. J. & Frier, B. M. Symptoms of hypoglycaemia in people with diabetes. Diabet. Med. 18, 690–705 (2001).
McCrimmon, R. J., Frier, B. M. & Deary, I. J., Appraisal of mood and personality during hypoglycaemia in human subjects. Physiol. Behav. 67, 27–33 (1999).
Inkster, B. & Frier, B. M. The effects of acute hypoglycaemia on cognitive function in type 1 diabetes. Br. J. Diabetes Vasc. Dis. 12, 221–226 (2012).
Inkster, B. & Frier, B. M. Driving and diabetes. Diabetes Obes. Metab. 15, 775–783 (2013).
Graveling, A. J. & Frier, B. M. Hypoglycaemia: an overview. Prim. Care Diabetes 3, 131–139 (2009).
Frier, B. M. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab. Res. Rev. 24, 87–92 (2008).
Frier, B. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 18 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 347–368 (Wiley Blackwell, 2014).
Wild, D. et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ. Couns. 68, 10–15 (2007).
Barendse, S., Singh, H., Frier, B. M. & Speight, J. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: a narrative review. Diabet. Med. 29, 293–302 (2012).
Leckie, A. M., Graham, M. K., Grant, J. B., Ritchie, P. J. & Frier, B. M. Frequency, severity, and morbidity of hypoglycemia occurring in the workplace in people with insulin-treated diabetes. Diabetes Care 28, 1333–1338 (2005).
Brod, M., Rana, A. & Barnett, A. H. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr. Med. Res. Opin. 28, 1–12 (2012).
Lawton, J. et al. Experiences, views, and support needs of family members of people with hypoglycemia unawareness: interview study. Diabetes Care 37, 109–115 (2014).
Wright, R. J. & Frier, B. M. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab. Res. Rev. 24, 353–363 (2008).
Sommerfield, A. J., Wilkinson, I. B., Webb, D. J. & Frier, B. M. Vessel wall stiffness in type 1 diabetes, and the central hemodynamic effects of acute hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 293, E1274–E1279 (2007).
Rana, O. et al. Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation 124, 1548–1556 (2011).
Lindström, T., Jorfeldt, L., Tegler, L. & Arnqvist, H. J. Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet. Med. 9, 536–541 (1992).
Desouza, C., Salazar, H., Cheong, B., Murgo, J. & Fonseca, V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 26, 1485–1489 (2003).
Koivikko, M. L. et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia 51, 426–435 (2008).
Robinson, R. T. et al. Mechanisms of abnormal cardiac repolarisation during insulin-induced hypoglycemia. Diabetes 52, 1469–1474 (2003).
Gill, G. V., Woodward, A., Casson, I. F. & Weston, P. J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes—the 'dead in bed' syndrome revisited. Diabetologia 52, 42–45 (2009).
Stahn, A. et al. Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias. Diabetes Care 37, 516–520 (2014).
Chow, E. et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 63, 1738–1747 (2014).
Jones, T. W. et al. Decreased epinephrine responses to hypoglycemia during sleep. N. Engl. J. Med. 338, 1657–1662 (1998).
Reno, C. M. et al. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes 62, 3570–3581 (2013).
Lee, S. P. et al. Influence of autonomic neuropathy on QTc interval lengthening during hypoglycemia in type 1 diabetes. Diabetes 53, 1535–1542 (2004).
Soydan, N. et al. Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes. Metabolism 62, 717–724 (2013).
Tattersall, R. B. & Gill, G. V. Unexplained deaths of type 1 diabetic patients. Diabet. Med. 8, 49–58 (1991).
Tanenberg, R. J., Newton, C. A. & Drake, A. J. Confirmation of hypoglycemia in the 'dead-in-bed' syndrome as captured by a retrospective continuous glucose monitoring system. Endocr. Pract 16, 244–248 (2010).
Tsujimoto, T. et al. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 37, 217–225 (2014).
Frier, B. M. & Hilsted, J. Does hypoglycaemia aggravate the complications of diabetes? Lancet 326, 1175–1177 (1985).
Giminez, M. et al. Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes. Diabetes Care 34, 198–203 (2011).
Wright, R. J. et al. Effects of acute insulin-induced hypoglycemia on indices of inflammation. Diabetes Care 33, 1591–1597 (2010).
Chow, E. Y. K., Iqbal, A., Phoenix, F., Heller, S. R. & Ajjan, R. A. Hypoglycaemia promotes thrombosis and inflammation for at least one week in patients with type 2 diabetes [abstract]. Diabetologia 56 (Suppl. 1), S243 (2013).
Robinson, A. M. et al. Antecedent hypoglycaemia in non-diabetic subjects reduces the adrenaline response for 6 days but does not affect the catecholamine response to other stimuli. Clin. Sci. (Lond.) 89, 359–366 (1995).
Adler, G. K. et al. Antecedent hypoglycemia impairs autonomic cardiovascular function. Implications for rigorous glycemic control. Diabetes 58, 360–366 (2009).
Heusch, G. et al. Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383, 1933–1943 (2014).
Schernthaner, G. Diabetes and cardiovascular disease: is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. Wien. Med. Wochenschr. 160, 8–19 (2010).
Frier, B. M., Schernthaner, G. & Heller, S. R. Hypoglycemia and cardiovascular risks. Diabetes Care 34 (Suppl. 2), S132–S137 (2011).
Bonds, D. E. et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 340, b4909 (2010).
ORIGIN Trial Investigators. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN Trial. Eur. Heart J. 34, 3137–3144 (2013).
Leese, G. P. et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes. A population-based study of health service resource use. Diabetes Care 26, 1176–1180 (2003).
Warren, R. E. & Frier, B. M. Hypoglycaemia and cognitive function. Diabetes Obes. Metab. 7, 493–503 (2005).
Zammitt, N. N., Warren, R. E., Deary, I. J. & Frier, B. M. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes. Effect of impaired awareness of hypoglycemia. Diabetes 57, 732–736 (2008).
Bjorgaas, M., Sand, T., Vik, T. & Jorde, R. Quantitative EEG during controlled hypoglycaemia in diabetic and nondiabetic children. Diabet. Med. 15, 30–37 (1998).
Perros, P. & Bjorgaas, M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 15 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 305–322 (Wiley Blackwell, 2014).
Tallroth, G., Ryding, E. & Agardh, C. D. Regional cerebral blood flow in normal man during insulin-induced hypoglycemia and in the recovery period following glucose infusion. Metabolism 41, 717–721 (1992).
Kennan, R. P., Takahashi, K., Pan, C., Shamoon, H. & Pan, J. W. Human cerebral blood flow and metabolism in acute insulin-induced hypoglycemia. J. Cereb. Blood Flow Metab. 25, 527–534 (2005).
MacLeod, K. M. et al. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 37, 257–263 (1994).
MacLeod, K. M. et al. The effects of acute hypoglycemia on relative cerebral blood flow distribution in patients with type 1 (insulin-dependent) diabetes and impaired hypoglycemia awareness. Metabolism 45, 974–980 (1996).
Chalmers, J. et al. Severe amnesia after hypoglycemia. Clinical, psychometric, and magnetic resonance imaging correlates. Diabetes Care 14, 922–925 (1991).
Bottcher, J. et al. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 36, e20–e22 (2005).
Cordonnier, C. et al. Serial diffusion and perfusion-weighted MR in transient hypoglycemia. Neurology 65, 175 (2005).
Arbelaez, A. M. & Hershey, T. Imaging hypoglycemia's effects on the human brain. Diabetic Hypoglycemia 3, 3–9 (2010).
Asvold, B. O., Sand, T., Hestad, K. & Bjorgaas, M. R. Cognitive function in type 1 diabetic adults with childhood exposure to severe hypoglycemia: a 16 year follow-up study. Diabetes Care 33, 1945–1947 (2010).
Ly, T. T., Anderson, M., McNamara, K. T., Davis, E. A. & Jones, T. W. Neurocognitive outcomes in young adults with early-onset type 1 diabetes. Diabetes Care 34, 2192–2197 (2011).
Northam, E. A. et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 32, 445–450 (2009).
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 356, 1842–1852 (2007).
Biessels, G. J. Hypoglycemia and cognitive decline in older people with type 2 diabetes: a bidirectional relationship. Diabetic Hypoglycemia 6, 11–14 (2014).
Yaffe, K. et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern. Med. 173, 1300–1306 (2013).
Feinkohl, I. et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 37, 507–515 (2014).
Ryan, C. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 14 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 285–304 (Wiley Blackwell, 2014).
Seaquist, E. R. et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, 1384–1395 (2013).
Cox, D. J., Gonder-Frederick, L., Ritterband, L., Clarke, W. & Kovatchev, B. P. Prediction of severe hypoglycemia. Diabetes Care 30, 1370–1373 (2007).
Siebenhofer, A. et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD003287. http://dx.doi.org/10.1002/14651858.CD003287.pub4.
Horvath, K. et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD005613. http://dx.doi.org/10.1002/14651858.CD005613.pub3.
Inkster, B., Zammitt, N. N. & Frier, B. M. Drug-induced hypoglycaemia in type 2 diabetes. Expert Opin. Drug Saf. 11, 597–614 (2012).
Buckingham, B. et al. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol. Ther. 7, 440–447 (2005).
Choudhary, P. et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care 36, 4160–4162 (2013).
Hanaire, H. et al. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab. 34, 401–423 (2008).
Pickup, J. C. & Sutton, A. J. Severe hypoglycaemia and glycaemic control in type 1 diabetes; meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet. Med. 25, 765–774 (2008).
Hovorka, R. Closed-loop insulin delivery: from bench to clinical practice. Nat. Rev. Endocrinol. 7, 385–395 (2011).
Renard, E., Cobelli, C. & Kovatchev, B. P. Closed loop developments to improve glucose control at home. Diabetes Res. Clin. Pract. 102, 79–85 (2013).
Ly, T. T. et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes. A randomized clinical trial. JAMA 310, 1240–1247 (2013).
Bergenstal, R. M. et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N. Engl. J. Med. 369, 224–232 (2013).
The author has received honoraria for giving lectures at scientific meetings arranged by Boehringer Ingelheim, Eli Lilly, Janssen, MSD, Novo Nordisk and Sanofi, and as a member of scientific advisory boards for the same pharmaceutical companies.
About this article
Cite this article
Frier, B. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol 10, 711–722 (2014). https://doi.org/10.1038/nrendo.2014.170
Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial
Diabetology International (2021)
Clinical Pediatric Endocrinology (2021)
Insulin degludec allows for better glycaemic control with a lower risk of hypoglycaemia in patients with chronic kidney disease and type 2 diabetes
Diabetes Research and Clinical Practice (2020)
Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey
BMJ Open (2020)
Prediction of Nocturnal Hypoglycemia in Adults with Type 1 Diabetes under Multiple Daily Injections Using Continuous Glucose Monitoring and Physical Activity Monitor